Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

Grade Last Price % Change Price Change
B 8.500 -3.35% -0.295
CPH closed down 3.35 percent on Friday, April 19, 2024, on 47 percent of normal volume.
Earnings due: May 9
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
Gapped Up Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -3.35%
Down 3 Days in a Row Weakness -3.35%
Gapped Down Weakness -3.35%
Fell Below 20 DMA Bearish -3.63%
Narrow Range Bar Range Contraction -3.63%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cipher Pharmaceuticals Inc. Description

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharma Pipe Pharmaceutical Pipeline RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Ulcer Dermatology Nail Psoriasis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Rheumatoid Arthritis

Is CPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.98
52 Week Low 3.11
Average Volume 50,938
200-Day Moving Average 5.604
50-Day Moving Average 7.938
20-Day Moving Average 8.810
10-Day Moving Average 8.789
Average True Range 0.437
RSI (14) 50.25
ADX 24.19
+DI 28.460
-DI 23.604
Chandelier Exit (Long, 3 ATRs) 8.669
Chandelier Exit (Short, 3 ATRs) 9.211
Upper Bollinger Bands 9.625
Lower Bollinger Band 7.995
Percent B (%b) 0.31
BandWidth 18.495
MACD Line 0.248
MACD Signal Line 0.320
MACD Histogram -0.0712
Fundamentals Value
Market Cap 229.75 Million
Num Shares 27 Million
EPS 0.28
Price-to-Earnings (P/E) Ratio 30.04
Price-to-Sales 0.85
Price-to-Book 0.55
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.265
Resistance 3 (R3) 9.323 9.127 9.138
Resistance 2 (R2) 9.127 8.932 9.098 9.095
Resistance 1 (R1) 8.813 8.811 8.715 8.755 9.052
Pivot Point 8.617 8.617 8.568 8.588 8.617
Support 1 (S1) 8.303 8.422 8.205 8.245 7.948
Support 2 (S2) 8.107 8.301 8.078 7.905
Support 3 (S3) 7.793 8.107 7.863
Support 4 (S4) 7.735